Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Camp4 Therapeutics Corp

NASDAQ: CAMP · Life Sciences · 3 alerts · CIK 1736730

Share price
$3.86Close, Nov 16
Market cap
$242M
Shares outstanding
62.75MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Camp4 Therapeutics Corp filings on SEC EDGAR ↗

4:48 PM ET 8-K
Investor Presentation

Camp4 Therapeutics Investor Presentation

CAMP4 Therapeutics held an Analyst Day meeting to present details on its planned Phase 1/2 ASCEND clinical trial of CMP-002 for SYNGAP1-related disorder. The company provided a comprehensive data presentation and updated its corporate pipeline overview, detailing the trial's design, inclusion criteria, and therapeutic dosing expectations.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.